Eli Lilly and Company kicked off the trading day on 09/16/19 with a price decrease of -0.69%, equivalent to -$0.76 relative change for the day. Taking a more long-term approach, LLY had a 52-week range of $104.17 to $132.13. At the time of this article’s publishing, this stock is trading at $110.13 after starting the trading session at $110.42. At the time of writing, this stock’s 50-day Moving Average stands at $110.85, while the 200-day Moving Average of this stock is currently $116.61.
Currently, this company’s share volume is sitting at $1,714,914, but has maintained average daily volume of $3.73M. This stock has generated an average Year to Date volume of $8.66 million, alongside an average 20-day volume of $3.16 million. This publicly-traded company’s shares outstanding now amounts to $970.48 million, simultaneously with a float of $963.60 million. The organization now has a market capitalization sitting at $106.88 billion.
Eli Lilly and Company(LLY) Ownership Data
Now let’s turn our focus to how large-scale investors are behaving with this stock. Eli Lilly and Company’s current insider ownership accounts for 12.20%, in contrast to 81.20% institutional ownership. According to the most recent latest insider trade that took place on Sep 05 this organization’s SVP, HR & Diversity sold 9,452 at the rate of 115.00, making the entire transaction hit 1,086,980 in total value, affecting insider ownership by 100,211. Preceding that transaction, on Sep 03 Company’s SVP & President, Lilly Int’l sold 19,500 at a price of 112.91, making the whole transaction’s value amount to 2,201,745. This particular insider is now the holder of 38,306 in total.
If we take a glance at the Ownership summary of Eli Lilly and Company’s stock, Institutional holders make up 81.20% of its total stock ownership. All together, they are the legal holders of 970.48M shares. If we focus on the top 3 stockholders for this publicly-traded organization, The Vanguard Group, Inc. owns 69,855,437 shares, with PRIMECAP Management Co. in 2nd place owning 43,163,120 shares and BlackRock Fund Advisors in third place with total ownership of 41,790,706 shares.
Eli Lilly and Company (LLY) Earnings and Revenue Data
In the latest quarterly report that this company released, which was put into the public domain on 6/29/2019, the organization reported $1.5 earnings per share (EPS) for the three-month period, surpassing the consensus estimate (set at $1.45) by $0.05.
This company achieved a net margin of 33.76 while generating a return on equity of 98.73. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.48 per share during the current fiscal year.
Eli Lilly and Company’s EPS increase for this current 12-month fiscal period is 102.80%, and is forecasted to reach 16.32% in the upcoming year. Looking at the long run, market analysts have predicted that Company’s EPS will increase by 10.10% through the next 5 years, which can be compared against the -5.30% growth it accomplished over the previous five years trading on the market.
Additional Trading Performance Indicators
Now turning our attention to the current performance indicators for Eli Lilly and Company, this organization’s Quick Ratio in the last reported quarter now stands at 0.90. The company has managed to achieve an average true range (ATR) of 2.35. Alongside those, its PE Ratio stands at $25.04, and its Beta score is 0.16.
Another valuable indicator worth considering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.60 for this organization. Similarly, its price to free cash flow for trailing twelve months is now 73.97. Plus, this company’s price to book ratio for the last three-month fiscal period reported is 36.47, whereas its price to cash per share for the last quarter landed at 2.44.
In the same vein, LLY’s Diluted EPS (Earnings per Share) trailing twelve months was posted at 4.40, a figure that is expected to reach 1.41 in the next reported quarter, and analysts expect it will be 16.32% at the market close of one year from today’s date.